| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) before provision for income taxes | 1,298,800 | 1,283,000 | 730,400 | 1,224,100 |
| Provision for income taxes | 215,900 | 250,100 | 84,100 | 178,700 |
| Net income (loss) | 1,082,900 | 1,032,900 | 646,300 | 1,045,400 |
| Basic (in dollars per share) | 4.24 | 4.02 | 2.52 | 4.05 |
| Basic (in shares) | 255,600,000 | 256,700,000 | 256,900,000 | 258,000,000 |
| Diluted (in dollars per share) | 4.2 | 3.99 | 2.49 | 4.01 |
| Diluted (in shares) | 257,600,000 | 258,900,000 | 259,500,000 | 261,000,000 |
VERTEX PHARMACEUTICALS INC MA (VRTX)
VERTEX PHARMACEUTICALS INC MA (VRTX)